Keyword: Bio-Rad Laboratories
Bio-Rad Laboratories received FDA clearance for two digital PCR products designed to monitor CML patients’ molecular responses to treatment.
Bio-Rad has kicked off 2017 with a bang, announcing it has inked a deal to acquire genetic analysis player RainDance Technologies for an undisclosed amount.
One year ago, Illumina announced it was teaming up with Bio-Rad Laboratories to develop a next-generation sequencing solution for single-cell analysis. The pair debuted the tool, which can help researchers create better models of disease, on Monday at the J.P. Morgan Healthcare Conference.